Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma

Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

(2016) Shahed N. Badiyan et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

(2016) Pascal Hammel et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer

(2016) W. L. Shaib et al.   ONCOLOGIST

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma

(2015) Eric A. Mellon et al.   ACTA ONCOLOGICA

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience

(2015) Shalini Moningi et al.   ANNALS OF SURGICAL ONCOLOGY

Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma

(2013) Deyali Chatterjee et al.   HISTOPATHOLOGY

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated

(2013) Michael D. Chuong et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

(2013) Brian A. Boone et al.   JOURNAL OF SURGICAL ONCOLOGY

Neoadjuvant GTX Chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer

(2011) Manish Patel et al.   JOURNAL OF SURGICAL ONCOLOGY

Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Pancreas

(2011) Kush Goyal et al.   JOURNAL OF SURGICAL RESEARCH

Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration

(2010) Francesco Polistina et al.   ANNALS OF SURGICAL ONCOLOGY

The Accordion Severity Grading System of Surgical Complications

(2009) Steven M. Strasberg et al.   ANNALS OF SURGERY

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

(2009) Daniel T. Chang et al.   CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY